Aggressive pharmacologic donor management results in more transplanted organs

Transplantation

Volumn 75, Issue 4, 2003, Pages 482-487

  Rosendale, John D ^a   Kauffman, H Myron ^a   McBride, Maureen A ^a   Chabalewski, Franki L ^a   Zaroff, Jonathan G ^b   Garrity, Edward R ^c   Delmonico, Francis L ^d   Rosengard, Bruce R ^a  

^a UNITED NETWORK FOR ORGAN SHARING   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIHYPERTENSIVE AGENT; DOBUTAMINE; DOPAMINE; LEVOTHYROXINE; LIOTHYRONINE; METHYLPREDNISOLONE; STEROID; VASODILATOR AGENT; VASOPRESSIN;

ADULT; ARTICLE; BRAIN DEATH; CADAVER DONOR; CALCULATION; CARDIOVASCULAR DISEASE; CELL VIABILITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG MECHANISM; FEMALE; HEART FUNCTION; HEART TRANSPLANTATION; HORMONAL REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; ORGAN DONOR; ORGAN PERFUSION; ORGAN TRANSPLANTATION; PANCREAS TRANSPLANTATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROBABILITY; RESUSCITATION; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; UNITED STATES; UNIVARIATE ANALYSIS;

ADULT; BRAIN DEATH; CHILD; CHILD, PRESCHOOL; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; RENAL AGENTS; RESUSCITATION; RETROSPECTIVE STUDIES; STEROIDS; THYROXINE; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS; TRIIODOTHYRONINE; VASOPRESSINS;

EID: 0037468454     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000045683.85282.93     Document Type: Article

References (19)

1. Organ Procurement and Transplantation Network [OPTN Website]. Available at www.optn.org. Accessed January 23, 2003.
2. Hosenpud JD, Bennett LE, Keck BM, et al. The Registry of the International Society for Heart and Lung Transplantation: Seventh Official Report-2000. J Heart Lung Transplant 2000; 19: 909-931.
3. 1 after clinical liver transplantation. Transplant Proc 1995; 27: 1862-1867.
4. Rosendale JD, Chabalewski FL, McBride MS, et al. Increased transplanted organs from the use of a standardized donor management protocol. Am J Transplant 2002; 2: 761-768.
5. Zaroff JG, Rosengard BR, Armstrong WF, et al. Consensus conference report: maximizing use of organs recovered from the cadaver donor: cardiac recommendations. Circulation 2002; 106: 836-841.
6. Rosengard BR, Feng S, Alfrey EJ, et al. Report of the Crystal City Meeting to Maximize the Use of Organs Recovered from the Cadaver Donor. Am J Transplant 2002; 2: 701-711.
7. Wheeldon DR, Potter CDO, Oduro A, et al. Transforming the "unacceptable" donor: outcomes from the adoption of a standardized donor management technique. J Heart Lung Transplant 1995; 14: 734-742.
8. Follette DM, Rudich SM, Babcock WD. Improved oxygenation and increased lung donor recovery with high-dose steroid administration after brain death. J Heart Lung Transplant 1998; 17: 423-429.
9. McBride MA, Peters TG, Henderson JM, et al. Expanded donor study. UNOS Report to the Health Resources & Services Administration, 1997, pp. 17-34.
10. Glasser M, Waaga AM, Laskowski IA, et al. Organ transplantation. From brain-dead donors: its impact on short- and long-term outcome revisited. Transplant Rev 2001; 15: 1-10.
11. Novitzky D, Cooper DKC, Reichert B. Hemodynamic and metabolic responses to hormonal therapy in brain-dead potential organ donors. Transplantation 1987; 43: 852-854.
12. Jeevanandam V, Todd B, Regillo T, et al. Reversal of donor myocardial dysfunction by triiodothyronine replacement therapy. J Heart Lung Transplant 1994; 13: 681-687.
13. Novitsky D, Cooper DKC, Morrell D, et al. Change from aerobic to anaerobic metabolism after brain death, and reversal following triiodothyronine therapy. Transplantation 1988; 45: 32-36.
14. Jonas M, Oduro A. Management of the multi-organ donor. In: Higgins RSD, Sanchez JA, Lorber MI, et al., eds. The multi-organ donor: selection and management. Malden, MA, Blackwell Science 1997, pp 123-139.
15. Salim A, Vassiliu P, Velmahos GC, et al. The role of thyroid hormone administration in potential organ donors. Arch Surg 2001; 136: 1377-1380.
16. Pennefather SH, Bullock RE, Mantle D, et al. Use of low dose arginine vasopressin to support brain-dead organ donors. Transplantation 1995; 59: 58-62.
17. Chen JM, Cullinane S, Spanier TB, et al: Vasopressin deficiency and pressor hypersensitivity in hemodynamically unstable organ donors. Circulation 1999; 100(suppl II): II-244-246.
18. Riou B, Dreaux S, Rochem S, et al. Circulating cardiac troponin T in potential heart transplant patients. Circulation 1995; 92: 409-414.
19. Mackersie RC, Bronsther OL, Shackford SR. Organ procurement in patients with fatal head injuries. Ann Surg 1991; 213: 143-150.